Effect of FOLFOX6 Chemotherapy on Serum VEGF Expression in Advanced Colorectal Cancer Patients
February 2019
in “
Revista da Associação Médica Brasileira
”
Studysummary This study found that FOLFOX6 chemotherapy significantly decreased serum VEGF and CRP levels in advanced colorectal cancer patients, improved their quality of life as measured by KPS scores, and demonstrated a high overall therapeutic efficacy of 82.72% with manageable side effects.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on scielo.br →